Sentante announced today that the FDA accepted its stroke treatment system into its Total Product Life Cycle Advisory Program (TAP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results